Position in BCRX
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$277,280
+$277,252 QoQ
Shares Held
27,728
+924166.7% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#186
of 316 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Bayforest Capital Ltd holds $1,146,366 across 9 Drug Manufacturers - Specialty & Generic names. BCRX ranks #2 (24.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRGO |
PERRIGO Co plc
|
39,667 | $412,140 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
This page
|
27,728 | $277,280 | |
| 3 | VTRS |
Viatris Inc
|
17,424 | $276,693 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
4,453 | $71,381 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
951 | $32,219 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
140 | $23,595 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
270 | $22,350 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
755 | $18,580 |
All Filings in BCRX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $277,280 | 27,728 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $28 | 3 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $66,136 | 8,479 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $531,535 | 70,031 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $839,749 | 93,722 | Shares | Sole | 2025-07-28 | |
| No filing history on record for this holder in this stock. | ||||||